相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study
Ute Spiekerkoetter et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis
Helene Barone et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2020)
Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches
Marie Canton et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2019)
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations
Jeffrey M. Chinsky et al.
GENETICS IN MEDICINE (2017)
Cognitive Profile and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
Rianne Jahja et al.
NEUROPSYCHOLOGY (2017)
Key European guidelines for the diagnosis and management of patients with phenylketonuria
Francjan J. van Spronsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study
Rianne Jahja et al.
BEHAVIOR GENETICS (2017)
Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
Maria Ignacia Garcia et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2017)
Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study
Rianne Jahja et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
Jerry Vockley et al.
GENETICS IN MEDICINE (2014)
Recommendations for the nutrition management of phenylalanine hydroxylase deficiency
Rani H. Singh et al.
GENETICS IN MEDICINE (2014)
Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone
Fatiha Bendadi et al.
JOURNAL OF PEDIATRICS (2014)
Recommendations for the management of tyrosinaemia type 1
Corinne de Laet et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?
A. Daly et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2012)
Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC
Eva Thimm et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec
Jean Larochelle et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1
Corinne De Laet et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis
Julia Albrecht et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
A. Masurel-Paulet et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
Susan E. Waisbren et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The genetic tyrosinemias
CR Scott
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2006)
Executive function impairment in early-treated PKU subjects with normal mental development
V Leuzzi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Tyrosinemia type II: Nine cases of ocular signs and symptoms
MS Macsai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
分享论文
